Imexpharm Corporation (HOSE:IMP)
39,800
+900 (2.31%)
At close: Aug 28, 2026
Imexpharm Market Cap
Imexpharm has a market cap or net worth of 6.13 trillion as of September 2, 2026. Its market cap has decreased by -24.19% in one year.
Market Cap
6.13T
Enterprise Value
5.82T
Revenue
2.32T
Ranking
n/a
PE Ratio
19.50
Stock Price
39,800.00
ChartMarket Cap Chart
Since April 2, 2007, Imexpharm's market cap has increased from 1.11T to 6.13T, an increase of 452.81%. That is a compound annual growth rate of 9.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 6.13T | -24.19% |
| Dec 31, 2025 | 8.09T | 11.70% |
| Dec 31, 2024 | 7.24T | 82.69% |
| Dec 29, 2023 | 3.96T | -1.28% |
| Dec 30, 2022 | 4.01T | -22.62% |
| Dec 31, 2021 | 5.19T | 38.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding